Korro Bio, Inc.
KRRONASDAQHealthcare● Active
$10.59
$-0.13(-1.21%)
Market Cap$105406157
P/E Ratio—
52W High$55.89
52W Low$5.204
Korro Bio, Inc. (KRRO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · KRRO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.39M | $2.27M | $0.00M | $0.00M | $14.07M |
| Cost of Revenue | $4.28M | $0.00M | $0.00M | $0.00M | $3.84M |
| Gross Profit | $2.11M | $2.27M | $0.00M | $0.00M | $10.23M |
| Gross Margin %(computed) | 33.04% | 100.00% | — | — | 72.70% |
| Operating Expenses | |||||
| R&D Expenses | $65.58M | $63.64M | $57.25M | $42.20M | $59.32M |
| G&A Expenses | $28.16M | $30.55M | $24.03M | $16.80M | $0.00M |
| Total Operating Expenses | $89.45M | $94.18M | $84.53M | $59.00M | $94.26M |
| Operating Income | ($87.34M) | ($91.91M) | ($84.53M) | ($59.00M) | ($84.03M) |
| Operating Margin %(computed) | — | — | — | — | -597.32% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.95M | $0.40M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.12M | $0.76M |
| Income Before Tax | ($116.62M) | ($83.44M) | ($81.14M) | ($58.02M) | ($84.67M) |
| Income Tax Expense | $0.64M | $0.14M | $0.03M | $0.01M | $0.01M |
| Net Income | ($117.26M) | ($83.58M) | ($81.17M) | ($58.03M) | ($84.69M) |
| Net Margin %(computed) | — | — | — | — | -601.98% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-12.48 | $-9.37 | $-53.09 | $-227.58 | $-4.94 |
| Wtd Avg Shares | 9.40M | 8.92M | 1.53M | 0.26M | 4.45M |
| EBITDA | ($83.06M) | ($88.34M) | ($80.90M) | ($56.49M) | ($80.07M) |
| EBITDA Margin %(computed) | — | — | — | — | -569.14% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Korro Bio, Inc. data
About Korro Bio, Inc. (KRRO) Income Statement
Korro Bio, Inc. (KRRO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, KRRO reported revenue of $0.01B, gross profit of $0.00B (gross margin 33.04%), and net income of ($0.12B) — a net profit margin of -1834.48%.
Frequently asked questions
KRRO · 4 questionsKorro Bio, Inc. (KRRO) reported revenue of $0.01B for 2025, up 181.5% year-over-year.
KRRO revenueKRRO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08